Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-057957
Filing Date
2025-03-19
Accepted
2025-03-19 17:27:12
Documents
6
Effectiveness Date
2025-03-19

Document Format Files

Seq Description Document Type Size
1 S-8 d933070ds8.htm S-8 34949
2 EX-5.1 d933070dex51.htm EX-5.1 11812
3 EX-23.1 d933070dex231.htm EX-23.1 1833
4 EX-FILING FEES d933070dexfilingfees.htm EX-FILING FEES 21625
5 GRAPHIC g933070g0308021858561.jpg GRAPHIC 1680
6 GRAPHIC g933070g0308024132421.jpg GRAPHIC 2592
  Complete submission text file 0001193125-25-057957.txt   77474
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285933 | Film No.: 25753781
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)